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Abstract 21 
Sialic acid (Neu5Ac) is commonly found in terminal location of colonic mucins glycans where 22 
it is a much-coveted nutrient for gut bacteria including Ruminococcus gnavus. R. gnavus is 23 
part of the healthy gut microbiota in humans but shows a disproportionate representation in 24 
diseases. There is therefore a need in understanding the molecular mechanisms 25 
underpinning its adaptation to the gut. Previous in vitro work demonstrated that R. gnavus 26 
mucin glycan-foraging strategy is strain-dependent and associated with the expression of an 27 
intramolecular trans-sialidase releasing 2,7-anhydro-Neu5Ac instead of Neu5Ac from 28 
mucins. Here, we have unravelled the metabolism pathway of 2,7-anhydro-Neu5Ac in R. 29 
gnavus which is underpinned by the exquisite specificity of the sialic transporter for 2,7-30 
anhydro-Neu5Ac, and by the action of an oxidoreductase converting 2,7-anhydro-Neu5Ac 31 
into Neu5Ac which then becomes substrate of a Neu5Ac-specific aldolase. Having 32 
generated a R. gnavus nan cluster deletion mutant that lost the ability to grow on sialylated 33 
substrates, we showed that in gnotobiotic mice colonised with R. gnavus wild-type and 34 
mutant strains, the fitness of the nan mutant was significantly impaired with a reduced ability 35 
to colonise the mucus layer. Overall, our study revealed a unique sialic acid pathway in 36 
bacteria, with significant implications for the spatial adaptation of mucin-foraging gut 37 
symbionts in health and disease.  38 
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 43 
Introduction 44 
The gastrointestinal (GI) tract is heavily colonized with bacteria that play a vital role in human 45 
health. The gut microbiota composition varies longitudinally along the GI tract but also 46 
transversally from the mucosa to the lumen1. In the colon, the epithelium is covered with a 47 
bi-layer of mucus, with the outer mucus layer providing a natural habitat for the commensal 48 
bacteria whereas the stratified inner mucus layer restricts bacterial access to the epithelium2. 49 
Mucin proteins that form the mucus layer are highly glycosylated with a diverse and complex 50 
array of O-glycan structures containing N-acetylgalactosamine, galactose and N-51 
acetylglucosamine (GlcNAc), and usually terminated by fucose, sialic acid (Neu5Ac) 52 
residues, and sulfate3,4. The terminal mucin glycans have been proposed to serve as 53 
metabolic substrates, providing a nutritional advantage to bacteria that have adapted to the 54 
GI mucosal environment5-7. The proportion of these terminal glycan epitopes varies along 55 
the GI tract with a decreasing gradient of fucose and an increasing gradient of sialic acid 56 
from the ileum to the rectum in humans8,9. Therefore, sialic acid represents a much-coveted 57 
source of nutrients for the gut bacteria inhabiting the mucus niche in the large intestine. 58 
In bacteria, the genes involved in sialic acid metabolism are usually found clustered together 59 
forming different nan gene clusters10-12. The canonical nanATEK cluster was first described 60 
in Escherichia coli encompassing genes encoding the enzymes N-acetylneuraminate lyase 61 
(NanA), epimerase (NanE), and kinase (NanK), necessary for the catabolism of sialic acid 62 
into N-acetylglucosamine-6-P (GlcNAc-6-P) following its transport through the major 63 
facilitator superfamily transporter NanT13,14. An alternative pathway for sialic acid metabolism 64 
has been discovered later in Bacteroides fragilis, relying on the action of an MFS transporter 65 
(NanT), an aldolase (NanL), a novel ManNAc-6-P epimerase (also named NanE), encoded 66 
in the nanLET operon and a hexokinase (RokA), converting Neu5Ac into GlcNAc-6-P15. 67 
GlcNAc-6-P is then converted into fructose-6-P, which is a substrate in the glycolytic 68 
pathway by genes encoding NagA (GlcNAc-6-P deacetylase) and NagB (glucosamine-6-P 69 
deaminase)16. The majority of bacteria that harbour a nan cluster colonize mucus regions of 70 
the human body10-12. To gain access to this substrate, bacteria are dependent on sialic acid 71 
release and uptake. Several gut bacteria species, including strains of Clostridia, Bacteroides, 72 
Bifidobacterium longum, Vibrio cholerae, Ruminococcus gnavus or Akkermansia muciniphila 73 
express sialidases to release sialic acid from their terminal location in mucins10.  74 
Since sialic acid cleavage takes place outside of the cell, bacteria have evolved multiple 75 
mechanisms to capture this important nutrient from their environment12,17. Such transport 76 
mechanisms involve the aforementioned NanT MFS transporter used by E. coli and B. 77 
fragilis, which in E. coli has been demonstrated biochemically to be a H+-coupled 78 
symporter18 or secondary transporters from the sodium solute symport (SSS) family, present 79 
in C. difficile and S. typhimurium19,20. High-affinity transport of sialic acid is mediated by 80 
substrate-binding protein-dependent systems, including a tripartite ATP-independent 81 
periplasmic (TRAP) transporter, SiaPQM, and ATP-binding cassette (ABC) transporters21-25. 82 
The sialic acid ABC transporters are classified into 3 types, SAT, SAT2 and SAT312,17. To 83 
date all these transporters have been shown to transport Neu5Ac, with some being able to 84 
also move the related sialic acid Neu5Gc and KDN26,27. 85 
R. gnavus is an early coloniser of the infant gut28 but persists in adults where it belongs to 86 
the 57 species detected in more than 90% of human faecal samples29. R. gnavus belongs to 87 
the Firmicutes division, Clostridia class and XIVa cluster, Lachnospiraceae family30 and is 88 
considered as a prevalent member of the ‘normal’ gut microbiota29,31. Further, R. gnavus 89 
shows a disproportionate representation in a number of diseases such as inflammatory 90 
bowel disease32-40. The ability of R. gnavus strains to utilise mucin glycans as a source 91 
nutrient is associated with the expression of an intramolecular trans-sialidase (IT-sialidase) 92 
that specifically cleaves off terminal α2–3-linked Neu5Ac from glycoproteins, releasing 2,7-93 
anhydro-Neu5Ac instead of Neu5Ac41-45. In R. gnavus ATCC 29149 and ATCC 35913 94 
strains, the IT-sialidase (RgNanH) is part of a nan cluster, which is induced when the cells 95 
are grown in the presence of mucin and absent in non-mucin glycan-degrading strains such 96 
as R. gnavus E143,45. We enzymatically synthesised 2,7-anhydro-sialic acid derivatives46, 97 
that were used to confirm the ability of IT-sialidase expressing R. gnavus strains to grow on 98 
2,7-anhydro-Neu5Ac as sole carbon source43. We proposed that the ability of R. gnavus 99 
strains to produce and metabolise 2,7-anhydro-Neu5Ac, provide them with a competitive 100 
nutritional advantage in mucus by scavenging sialic acid from mucins in a form that others 101 
do not have access to43,44.  102 
In order to test this hypothesis and gain insights into R. gnavus 2,7-anhydro-Neu5Ac 103 
metabolism pathway, we identified candidate genes of the nan cluster involved in 2,7-104 
anhydro-Neu5Ac transport and metabolism and characterised the proteins. Using 105 
fluorescence spectroscopy, STD-NMR and ITC, we showed that the solute binding protein 106 
(SBP) from R. gnavus ABC transporter was specific for 2,7-anhydro-Neu5Ac. Further 107 
biochemical analyses uncovered an oxidoreductase activity allowing the conversion of 2,7-108 
anhydro-Neu5Ac into Neu5Ac and confirmed the specificity of the sialic acid aldolase for 109 
Neu5Ac. Finally, we showed that the nan cluster was essential to support anaerobic growth 110 
of the bacteria on sialoconjugates in vitro and for in vivo fitness using gnotobiotic mice 111 
colonised with R. gnavus wild-type or nan mutant. These data demonstrate a unique sialic 112 
acid metabolism pathway in bacteria, which provides R. gnavus with a competitive strategy 113 
to colonise the mucus niche. 114 
 115 
Results 116 
Identification of genes involved in 2,7-anhydro-Neu5Ac metabolism in R. gnavus nan 117 
cluster  118 
We first analysed the transcriptional activity of the nan cluster by qRT-PCR in R. gnavus 119 
ATCC 29149 grown on 2,7-anhydro-Neu5Ac or α2–3-sialyllactose (3’SL) as the sole carbon 120 
source. Expression of all genes constituting the nan cluster was induced upon bacterial 121 
growth on 2,7-anhydro-Neu5Ac or 3’SL as compared to glucose whereas the expression of 122 
the two genes flanking the cluster (RUMGNA_02702, RUMGNA_02690) remained 123 
unchanged (Figure 1). The 3’SL and 2,7-anhydro-Neu5Ac induced the transcription of the 124 
nan genes between 10 and 80-fold. Both substrates induced similar changes, which is not 125 
unexpected as 2,7-anhydro-Neu5Ac is the sialic acid form produced by R. gnavus ATCC 126 
29149 from 3’SL. These results indicate that the R. gnavus nan operon is dedicated to the 127 
metabolism of 2,7-anhydro-Neu5Ac from host sialoglycans.  128 
A sequence similarity network (SSN) analysis was then conducted to identify the proteins 129 
encoded by the nan cluster, which are associated with the ability of the bacteria to 130 
metabolise 2,7-anhydro-Neu5Ac over Neu5Ac. As expected, the IT-sialidase from R. gnavus 131 
strains clustered together with proteins from S. pneumoniae strains whose genomes are 132 
known to encode IT-sialidases (in addition to other sialidases)47,48 (Supplementary Figure 133 
1a). Other co-occurring bacterial species include Rumminococcus torques, Lactobacillus 134 
salivarius, Staphylococcus pseudintermedius, Streptococcus infantis and Streptococcus 135 
mitis. Bacterial species clustering for RgNanH, also shared clusters for proteins encoding 136 
RUMGNA_02698, the predicted solute binding protein (SBP) giving specificity to ABC 137 
transporters, RUMGNA_02692 (sialic acid aldolase), the first protein of the canonical 138 
Neu5Ac metabolism,  and RUMGNA_02695, a putative oxidoreductase, suggesting that 139 
these proteins may be associated with 2,7-anhydro-Neu5Ac metabolism (Supplementary 140 
Figure 1 and Supplementary Table 1). In contrast, RUMGNA_02701 with homology to 141 
sialic acid esterase proteins and RUMGNA_02700 with homology to the YhcH protein family 142 
did not cluster with proteins from the same set of bacteria (Supplementary Figure 1 and 143 
Supplementary Table 1). The candidate genes were then heterologous expressed, and the 144 
recombinant proteins purified as described in Methods. 145 
 146 
Specificity of R. gnavus sialic acid transporter for 2,7-anhydro-Neu5Ac  147 
We first investigated the ligand specificity of the recombinant SBP (RUMGNA_02698), 148 
RgSBP, by measuring changes in the intrinsic protein fluorescence upon addition of potential 149 
ligands. Addition of 10 µM or 20 µM 2,7-anhydro-Neu5Ac resulted in a significant shift at 350 150 
nm, causing an ~16% quench in the fluorescence (Figure 2a). In marked contrast, addition 151 
of Neu5Ac at 10 µM, 20 µM or 70 µM caused no change in the spectrum intensity, 152 
suggesting an absence of binding (Figure 2b). Titration of 0.5 µM RgSBP with 2,7-anhydro-153 
Neu5Ac resulted in a hyperbolic curve with a Kd of 1.349 µM (+/- 0.046) (Figure 2c). To 154 
confirm the specificity of 2,7-anhydro-Neu5Ac over Neu5Ac we monitored sequential 155 
changes in fluorescence following additions of 10 μM of the two ligands. When Neu5Ac was 156 
added first, no change in fluorescence was observed and a quench was observed following 157 
addition of 2,7-anhydro-Neu5Ac (Figure 2d). Conversely, when 2,7-anhydro-Neu5Ac was 158 
added first the quench was observed and additions of 10 μM Neu5Ac caused no further 159 
change in the intensity (Figure 2d), indicating that Neu5Ac is unable to displace 2,7-160 
anhydro-Neu5Ac, and further supporting the specificity of the interaction between RgSBP 161 
and 2,7-anhydro-Neu5Ac.  162 
The affinity of the interaction between RgSBP and sialic acid ligands was further assessed 163 
by isothermal titration calorimetry (ITC). RgSBP bound to 2,7-anhydro-Neu5Ac with a Kd of 164 
2.42 ± 0.27 μM (Figure 3a) and no binding was observed when Neu5Ac was used as the 165 
ligand (Figure 3b), in agreement with the findings from fluorescence spectroscopy. The 166 
binding of 2,7-anhydro-Neu5Ac revealed a thermodynamic signature with both entropic (-167 
T∆S -7.05 ± 0.08 kcal mol-1) and enthalpic (∆H -0.93 ± 0.03 kcal mol-1) components 168 
contributing favourably to the binding process (∆G -7.99 ± 0.05 kcal mol-1 Figure 3a). 169 
To gain structural insights into the unique ligand specificity of RgSBP, saturation transfer 170 
difference nuclear magnetic resonance spectroscopy (STD NMR) studies were conducted 171 
with RgSBP in the presence of 2,7-anhydro-Neu5Ac or Neu5Ac. The transfer of 172 
magnetization as saturation from the protein to the ligand was clearly observed for 2,7-173 
anhydro-Neu5Ac but not for Neu5Ac, confirming that RgSBP preferentially selects 2,7-174 
anhydro-Neu5Ac (Supplementary Figure 2). STD NMR epitope binding revealed that 175 
protons H3, H4 and H6 showed the highest STD (%) factors, indicating the close contacts 176 
present at the interface of binding (Figure 3c). On the other hand, protons H7, H8, H9 and 177 
protons belonging to the CH3 group showed lower STD (%) and are expected to be more 178 
exposed to solvent. For the DEEP-STD NMR experiment, TEMPOL was used to gain 179 
insights into RgSBP binding pocket (Supplementary Figure 3). We found that protons H4, 180 
H6, H7, H8, H9’ were preferentially oriented toward aromatic residues while H3 and protons 181 
belonging to the CH3 group were oriented toward aliphatic residues (Figure 3d). 182 
Together these data demonstrate that RgSBP specifically binds to 2,7-anhydro-Neu5Ac but 183 
not to Neu5Ac, in line with the growth profile of R. gnavus ATCC 29149 on these 184 
substrates43. 185 
 186 
Specificity of R. gnavus sialic acid aldolase for Neu5Ac 187 
The substrate specificity of recombinant sialic acid aldolase (RUMGNA_02692; RgNanA), 188 
was determined using a coupled activity assay where pyruvate released during the 189 
conversion of Neu5Ac to ManNAc is converted to lactate by a lactate dehydrogenase and 190 
the subsequent decrease in absorbance at 340 nm measured as NADH is converted to 191 
NAD+. RgNanA and EcNanA (E. coli Neu5Ac lyase/aldolase used as a control) showed 192 
activity against Neu5Ac whilst neither enzyme showed activity against 2,7-anhydro-Neu5Ac 193 
(Figure 4a). The product of the reaction with Neu5Ac was confirmed to be ManNAc by 194 
HPLC (Supplementary Figure 4). RgNanA showed a kcat of 2.757 ± 0.033 s-1 and a KM of 195 
1.473 ± 0.098 mM (Figure 4b). These kinetic parameters are consistent with values from 196 
other bacterial sialic acid aldolases characterised to date (Supplementary Table 2).  197 
The RgNanA crystal structure presents as a (β/α8) TIM barrel with an adjacent three-helix 198 
bundle (for data collection and refinement statistics see Supplementary Table 3), a fold 199 
shared with characterised Neu5Ac aldolases from Staphylococcus aureus, E. coli, 200 
Fusobacterium nucleatem, Pasteurella multocida, and Haemophilus influenzae49-54 201 
(Supplementary Figure 5a). The active site residues in EcNanA, Ser47, Tyr110, and 202 
Tyr137, identified to be catalytically important are conserved in RgNanA55 (Figure 4c and 203 
Supplementary Figure 5b), supporting Neu5Ac specificity. The crystal structure of the 204 
complex between an inactive mutant, RgNanA K167A, and Neu5Ac showed Neu5Ac in the 205 
open-chain ketone form, with the N-acetyl group oriented out of the active site (Figure 4d). 206 
Neu5Ac forms extensive interactions with the enzyme active site (Supplementary Table 4). 207 
The Tyr139 α-carbon was shifted 1.8 Å in the mutant compared to wild-type. This movement 208 
is also present in the apo crystal structure, therefore presumably due to the absence of 209 
Lys167 rather than the presence of Neu5Ac (Supplementary Figure 5c).  210 
 211 
Conversion of 2,7-anhydro-Neu5Ac to Neu5Ac by RUMGNA_02695 212 
RUMGNA_02695 is a putative oxidoreductase with a predicted Rossman fold. Therefore, the 213 
activity of the recombinant protein was determined in the presence or absence of NAD+, 214 
NADH or FAD as potential cofactors. Reaction products were analysed by HPLC following 215 
DMB labelling of the sialic acid46. When 2,7-anhydro-Neu5Ac (which cannot be labelled by 216 
DMB) was used as a substrate, Neu5Ac was produced in the presence of NAD+ or NADH, 217 
but not in the presence of FAD or in the absence of a cofactor (Figure 5a). Mass 218 
spectrometry analyses showed a ratio of 1:2 for 2,7-anhydro-Neu5Ac:Neu5Ac 219 
(Supplementary Figure 6a), indicating that the reaction may be reversible. This was 220 
confirmed enzymatically by assaying RUMGNA_02695 against Neu5Ac in the presence of 221 
NAD+ or NADH, producing a 1:2 for 2,7-anhydro-Neu5Ac:Neu5Ac. Additionally, these data 222 
indicate that Neu5Ac is the favourable product (Supplementary Figure 6b). No net change 223 
in NADH concentration was observed during the conversion reaction using 2,7-anhydro-224 
Neu5Ac or Neu5Ac as substrate, suggesting that the enzyme mechanism may involve 225 
oxidation and reduction of NADH cofactor (Supplementary Figure 6c). The kinetic 226 
parameters of the enzymatic reaction were therefore determined using the coupled reaction 227 
described above in the presence of an excess of sialic acid aldolase and increasing 228 
concentrations of 2,7-anhydro-Neu5Ac substrate (Figure 5b). Using these conditions, the 229 
kcat was calculated to be 0.0824 ± 0.0043 s-1 and the KM 0.074 ± 0.014 mM. Taken together 230 
these data indicate that RUMGNA_02695 is an oxidoreductase required for the conversion 231 
of 2,7-anydro-Neu5Ac into Neu5Ac, which will then become a substrate for RgNanA. We will 232 
refer to RUMGNA_02695 as RgNanOx in the rest of the study. 233 
 234 
Impact of R. gnavus nan cluster on in vitro growth and in vivo colonisation of mice 235 
The ClosTron transformation method56 was successfully applied to R. gnavus ATCC 29149, 236 
enabling the generation of nan deletion mutants with an erythromycin resistance gene 237 
present in either the sense or antisense direction (relative to RgNanH). The recombination 238 
event was confirmed by PCR (Supplementary Figure 7a) and the expression of the full 239 
cluster tested by qPCR (Supplementary Figure 7b). The expression of the genes flanking 240 
the cluster, RUMGNA_02690 and RUMGNA_02702, showed levels comparable to the wild-241 
type strain, as also observed for the first three genes of the nan cluster, RUMGNA_02701-242 
02699, however, the nan cluster genes RUMGNA_02698-02691 showed significantly 243 
reduced expression compared to the wild-type strain. R. gnavus ATCC 29149 wild-type 244 
strain was able to utilise both 3’SL and 2,7-anhydro-Neu5Ac as a sole carbon source, while 245 
no growth was detected using the nan deletion mutants on these substrates 246 
(Supplementary Figure 8). 247 
To assess the impact of the nan cluster on the fitness of R. gnavus in vivo, germ-free 248 
C57BL/6J mice were gavaged with 1x108 CFU R. gnavus ATCC 29149 or R. gnavus 249 
antisense nan deletion mutant or a mixture of wild-type and nan mutant strains at 1x108 CFU 250 
each (Figure 6). During mono-colonisation experiments, both strains were detectable in the 251 
faecal content at day 3, 7 and 14 post-gavage at mean levels of between 1x106 and 1x107 252 
bacteria per mg of material (Figure 6a). Both strains were also detected in the caecal 253 
content of mono-colonised mice sacrificed at day 14. The absence of the nan cluster did not 254 
affect the mouse expression response, as shown by RNA seq (Supplementary Figure 9). In 255 
competition experiments,  the wild-type strain reached mean colonisation levels comparable 256 
to the levels obtained during mono-colonisation, whereas the mutant strain was severely 257 
outcompeted, reaching only 2x104 copies per mg at day 3, before decreasing further at day 7 258 
and day 14 below the level of detection in the faecal and caecal contents (Figure 6b). The 259 
impact of the nan deletion on the location of R. gnavus within the mucus layer was 260 
determined in mono-colonised mice by measuring the distance of the nan mutant or wild-261 
type R. gnavus strains to the epithelial layer throughout the colon by fluorescent in situ 262 
hybridization (FISH) staining using confocal microscopy. The data showed that the nan 263 
mutant resided 19.70 µm from the epithelial layer, 5.06 µm further away than the wild-type 264 
strain, 14.64 µm (Figure 6c&d).  265 
 266 
Discussion 267 
Sialic acid comprises a family of 9-carbon acidic sugar found predominantly on the cell-268 
surface glycans of humans and other animals. Neu5Ac, the most common form of sialic acid 269 
in humans, is a major epitope of mucin glycans which can serve as a metabolic substrate to 270 
the gut bacteria which have adapted to the mucosal environment6,10. In vivo, sialic acids may 271 
be modified by O-acetylation, O-methylation 9,10,57-59. Sialic acid metabolism is vital to the 272 
ability of R. gnavus strains to utilise mucin as a nutrient source43-45. R. gnavus ATCC 29149 273 
strain encodes an extended nan operon dedicated to the metabolism of 2,7-anhydro-Neu5Ac 274 
from host sialoglycans.  275 
Before being metabolised, a functional sialic acid transporter is essential for the uptake of 276 
sialic acid derivatives into the bacterial cell. The R. gnavus ATCC 29149 nan cluster 277 
contains a single ABC transporter, orthologous to the uncharacterised Steptococcus 278 
pneumoniae SAT2 system (Sp_1690-2), including two permeases (RUMGNA_02696 and 279 
02697) and RgSBP (RUMNGA_02698). R. gnavus SAT2 transporter is expected to be 280 
coupled with an MsiK-like ATPase encoded elsewhere in the genome, with 281 
RUMGNA_03040 sharing 59% identity with the S. pneumoniae MsiK. Interestingly, in 282 
contrast to S. pneumoniae, R. gnavus does not encode SAT or SAT3 transporters which are 283 
known to recognise Neu5Ac with SAT3 being required for growth on Neu5Ac 60-62. 284 
By studying RgSBP subunit, we have discovered that SAT2 is a specific transporter for 2,7-285 
anhydro-Neu5Ac with a Kd of 2.42 ± 0.27 μM, which does not bind Neu5Ac. Using STD NMR 286 
and DEEP-STD NMR, we characterized the orientation of the ligand in the binding site and 287 
the contribution of aromatic and aliphatic residues in RgSBP 2,7-anhydro-Neu5Ac binding 288 
pocket. The lower affinity as compared to bacterial SAT (SatA) transporters specific for 289 
Neu5Ac characterised to date, which bind in the nM range63, might be consistent with the 290 
‘exclusive’ access of the bacteria to the 2,7-anhydro-Neu5Ac substrate. Taken together 291 
these findings indicate that the ability of R. gnavus strains to grow on 2,7-anhydro-Neu5Ac 292 
(and not on Neu5Ac) can be explained by the exquisite specificity of RgSBP 293 
(RUMGNA_02698) RgSBP is also orthologous (72% identity/86% similarity) with the SBP 294 
from the putative sialic transporters in Streptococcus sanguinis SK36 (SSA_0076) and 295 
Streptococcus gordonii str. Challis substr. CH1 (SGO_0122)12. It would therefore be of 296 
interest to determine the specificity of Streptococcus SBPs towards 2,7-anhydro-Neu5Ac.  297 
Once inside the cell, 2,7-anhydro-Neu5Ac needs to be converted back into Neu5Ac to 298 
become a substrate for the sialic acid aldolase. RgNanOx (RUMGNA_02695) was identified 299 
as the oxidoreductase catalyzing the conversion of 2,7-anhydro-Neu5Ac into Neu5Ac, 300 
following a mechanism of action which remains to be determined. Bioinformatic analysis 301 
identified close homologous of this protein in a range of bacterial species, including YjhC 302 
from E. coli (Supplementary Figure 1, Supplementary Table 1).   Neu5Ac is then 303 
converted into ManNAc and pyruvate via the action of RgNanA (RUMGNA_02692), a 304 
Neu5Ac-specific aldolase with conserved structural features with NanA proteins from the nan 305 
canonical pathway. 306 
MultiGeneBlast analysis revealed that predicted homologs of the R. gnavus nan cluster are 307 
shared by a limited number of species, including 37 homologous clusters in S. pneumoniae 308 
isolates, S. suis A7, Blautia hansenii DSM 20583, Blautia sp. YL58 and Intestinimonas 309 
butyriciproducens AF211 (Supplementary Figure 10 & 11 and Supplementary Table 5). 310 
The presence of this cluster in S. pneumoniae suggests that it can also transport this 311 
unusual sialic acid into the cell. A major difference between NanB/NanH IT-sialidase and 312 
NanC sialidase cluster types is the associated transporter class, a carbohydrate ABC 313 
transporter for NanB/NanH as opposed to a sodium:solute symporter in NanC clusters47, 314 
which may indicate a difference in the form of sialic acid being transported. These 315 
bioinformatics analyses support the specialization of the R. gnavus nan cluster. 316 
We confirmed the importance of this metabolic pathway (Supplementary Figure 12) by 317 
generating a R. gnavus nan deletion mutant that was tested in vitro and in vivo using germ-318 
free mice. In in vivo competition experiments, the fitness of the mutant was impaired as 319 
compared to the wild-type strain with a reduced ability to colonise the mucus layer. The nan 320 
cluster is therefore important to maintain the spatial distribution of R. gnavus strains in the 321 
gut. The ability for R. gnavus strains harbouring a nan cluster to penetrate further down into 322 
the mucus layer may contribute to protect the bacteria from the constant mucus turner-over. 323 
This mechanism may serve as a determinant underlying R. gnavus success as one of the 324 
most largely shared species among individuals29,31.  325 
Together these findings provide robust biochemical and in vivo evidence for the role of R. 326 
gnavus nan cluster in the adaptation of this important gut symbiont to the mucosal 327 
environment in the gut, providing defined molecular targets for biomarkers and therapeutic 328 
strategies. 329 




All chemicals were obtained from Sigma (St Louis, USA) unless otherwise stated. D-glucose 334 
(Glc), N-acetylneuraminic acid (Neu5Ac), were purchased from Sigma-Aldrich (St Louis, 335 
MO). 3′-sialyllactose (3′SL) was purchased from Carbosynth Limited (Campton, UK). 2,7-336 
anhydro-Neu5Ac was prepared as previously described46,64.  337 
 338 
Bacterial strains and media 339 
R. gnavus ATCC 29149 was routinely grown in an anaerobic cabinet (Don Whitley, Shipley, 340 
UK) in BHI-YH as previously described45. Growth on single carbon sources utilized 341 
anaerobic basal YCFA medium65 supplemented with 11.1 mM of specific mono- or 342 
oligosaccharides (2,7-anhydro-Neu5Ac, 3’Sialyllactose (3’SL) or glucose). The bacteria were 343 
grown to late exponential phase for RNA extraction, the culture was performed in 14 ml 344 
tubes. Growth was determined spectrophotometrically by monitoring changes in optical 345 
density at 600 nm compared to the same medium without bacterium (∆ OD595 nm) hourly for 346 
10 hours. 347 
 348 
Quantitative real-time PCR (qRT-PCR) 349 
Total RNA was extracted from 3 ml of mid- to late exponential phase cultures of R. gnavus 350 
ATCC 29149 in YCFA supplemented with one carbon source (Glc, 3′SL or 2,7-anhydro-351 
Neu5Ac). Three biological replicates were performed for each carbon source. The RNA was 352 
stabilized prior to extraction by using RNAprotect Bacteria Reagent (Qiagen, Crawley, UK) 353 
according to the manufacturer’s instructions. The RNA was then extracted after an 354 
enzymatic lysis followed by a mechanical disruption of the cells, using the RNeasy Mini Kit 355 
(Qiagen) according to manufacturer's instructions with an on-column DNAse treatment. The 356 
purity and quantity of the extracted RNA was assessed with NanoDrop 1000 UV-Vis 357 
Spectrophotometer (Thermo Fischer Scientific, Wilmington, DE) and with Qubit 2.0 358 
(Invitrogen). 359 
qPCR was carried out in an Applied Biosystems 7500 Real-Time PCR system (Life 360 
Technologies Ltd). One pair of primers was designed for each target gene using 361 
ProbeFinder version 2.45 (Roche Applied Science, Penzberg, Germany) to obtain an 362 
amplicon of around 60–80 bp long. The primers were between 18 and 23 nt-long, with a Tm 363 
of 59–60°C (Supplementary Table S6). Calibration curves were prepared in triplicate for 364 
each pair of primers using 2.5-fold serial dilutions of R. gnavus ATCC 29149 genomic DNA. 365 
The standard curves showed a linear relationship of log input DNA vs. the threshold cycle 366 
(CT), with acceptable values for the slopes and the regression coefficients (R2). The 367 
dissociation curves were also performed to check the specificity of the amplicons. Each 368 
DNAse-treated RNA (1 µg) was converted into cDNA using QuantiTect® Reverse 369 
Transcription kit (Qiagen) according to the manufacturer’s instructions. DNAse-treated RNA 370 
was also treated the same way but without addition of the reverse-transcriptase (RT−). Each 371 
qPCR reaction (10 µl) was then carried out in triplicate with 1 µl of 1 ng/μl (cDNA or RT−) 372 
and 0.2 µM of each primer, using the QuantiFast SYBR Green PCR kit (Qiagen) according 373 
to the manufacturer’s instructions (except for the combined annealing/extension step which 374 
was extended to 35 s). Data obtained with cDNA were analyzed only when CT values above 375 
36 were obtained for the corresponding RT−. For each cDNA sample, the 3 CT values 376 
obtained for each gene were analyzed using the 2−∆∆CT method using housekeeping gyrB 377 
(RUMGNA_00867) gene as a reference gene and glucose as a reference condition. For 378 
each gene in each condition, the final value of the relative level of transcription (expressed 379 
as a fold change in gene transcription compared to glucose) is an average of 3 biological 380 
replicates, 1-way Annova was used for statistical analysis, using Graph Pad Prism (V 5.03).  381 
 382 
Cloning, expression, mutagenesis and purification of recombinant proteins 383 
R. gnavus ATCC 29149 genomic DNA (gDNA) was purified from the cell pellet of a bacterial 384 
overnight culture (1 ml) following centrifugation (5,000 g, 5 min) using the GeneJET 385 
Genomic DNA Purification Kit (ThermoFisher, UK), according to the manufacturer’s 386 
instructions. 387 
The full-length RgSBP excluding the signal sequence (residues 1–29), the full length 388 
RgNanA and full length RUMGNA_02695 were amplified from R. gnavus ATCC 29149  389 
gDNA, and cloned into the pEHISTEV66 expression system, introducing a His-tag at the N 390 
terminus using primers listed in Supplementary Table S6. DNA manipulation was carried out 391 
in E. coli DH5α cells. Sequences were verified by DNA sequencing by Eurofins MWG 392 
(Ebersberg, Germany) following plasmid preparation using the Monarch Plasmid Miniprep kit 393 
(New England Biolabs). The RgNanA active site mutant, K167A, was generated using the 394 
QuikChange Lightning mutagenesis kit (Agilent) and primers listed in Supplementary Table 395 
S6. E. coli BL21 (New England BioLabs) cells were transformed with the recombinant 396 
plasmid harbouring the gene of interest according to manufacturer's instructions. Expression 397 
was carried out in 800 ml ‘Terrific Broth Base with Trace Elements' autoinduction media 398 
(ForMedium, Dundee, UK) growing cells for 3 h at 37 °C and then at 16 °C for 48 h, with 399 
shaking at 250 rpm. The cells were harvested by centrifugation at 10,000 g for 20 min. The 400 
His-tagged proteins were purified by immobilized metal affinity chromatography (IMAC) and 401 
further purified by gel filtration (Superdex 75 column) on an Akta system (GE Health Care 402 
Life Sciences, Little Chalfont, UK). Protein purification was assessed by standard SDS–403 
polyacrylamide gel electrophoresis using NuPAGE Novex 4–12% Bis-Tris gels (Life 404 
Technologies, Paisley, UK). Protein concentration was measured with NanoDrop 1000 UV-405 
Vis Spectrophotometer (Thermo Fischer Scientific, Wilmington, DE) and using the extinction 406 
coefficient calculated by Protparam (ExPASy-Artimo, 2012) from the peptide sequence. 407 
 408 
Fluorescence spectroscopy  409 
All protein fluorescence experiments used a FluoroMax 3 fluorescence spectrometer with 410 
connecting water bath at 37°C. Because of the presence of 15 tyrosine residues, the protein 411 
was excited at 297 nm with slit widths of 5 nm. Under these conditions, the protein has a 412 
maximal emission at 331 nm. RgSBP was used at a concentration of 0.2 µM in 50 mM Tris 413 
pH 7.5 for all fluorescence experiments. Cumulative fluorescence changes from titration of 414 
the protein with ligand were plotted in GraphPad and fitted to a single rectangular hyperbola. 415 
The Kd values reported were averaged from three separate ligand titration experiments.  416 
 417 
Isothermal titration calorimetry (ITC) 418 
Isothermal titration calorimetry (ITC) experiments were performed using the PEAQ-ITC 419 
system (Malvern, Malvern, UK) with a cell volume of 200 µl. Prior to titration, protein samples 420 
were exhaustively dialysed into 50 mM Tris-HCl pH 7.5. The ligand was dissolved in the 421 
dialysis buffer. The cell protein concentration was 100 µM and the syringe ligand 422 
concentration was 2 mM. Controls with titrant (sugar) injected into the buffer only were 423 
subtracted from the data. The analysis was performed using the Malvern software, using a 424 
single-binding site model. Experiments were carried out in triplicate. 425 
 426 
Sialic acid aldolase activity assays  427 
Aldolase activity was measured by monitoring the decrease in absorbance at 340 nm 428 
(A340nm) as NADH is converted to NAD by lactate dehydrogenase in a coupled reaction 429 
where pyruvate is released from sialic acid by the aldolase. Reactions were performed in a 430 
100 µl volume with final concentrations of 150 µM NADH (Sigma, St Louis, USA), 0.5 U LDH 431 
(Sigma, St Louis, USA), 10 mM sialic acid (Neu5Ac or 2,7-anhydro-Neu5Ac) and 1.5 µg 432 
purified RgNanA or EcNanA (E. coli aldolase CAS: 9027-60-5, Carbosynth, UK) in 50 mM 433 
Na-phosphate buffer (pH 7.0).  The reactions were performed at 37 °C and monitored using 434 
FLUOstar OPTIMA (BMG LABTECH). For kinetics experiments, the sialic acid concentration 435 
was varied at 20, 10, 5, 4, 2, 1, 0.4, 0.2, 0.1 mM and the initial rate of reaction determined for 436 
each concentration in triplicate before analysis was performed by fitting the data to a 437 
Michaelis-Menten using Graph Pad Prism (V 5.03). 438 
To monitor the production of ManNAc during the aldolase-catalyzed reactions, 2-AB labelling 439 
was carried out on the products from the above reactions. Briefly, 50 ng GlcNAc was added 440 
to 10 µl of each sample as an internal reference, before drying using a Concentrator Plus 441 
(Eppendorf). 5 μl of labelling reagent was added and incubated at 65 °C for 3 h. The 442 
labelling reagent was prepared by dissolving 50 mg 2-aminobenzamide in a solution 443 
containing 300 μl acetic acid and 700 μl DMSO, before 60 mg sodium cyanoborohydride is 444 
added. Following addition of H2O to reach 100 μl total volume, the sample was transferred to 445 
a HPLC vial and 10 µl loaded onto a HyperClone 3u ODS (C18) 120A 150x4.6 mm 3 μ 446 
column. Mobile phases of 0.25% n-butylamine, 0.5% phosphoric acid, 0.1% 447 
Tetrahydrofurane; 50% methanol; Acetonitrile and H2O were used at a 0.7 ml/min flow rate.  448 
 449 
Bioinformatics analyses 450 
Sequence Similarity Networks (SSN) The InterPro families for RgNanH (Glycoside 451 
Hydrolase, family 34; IPR001860) and RgNanA (N-acetylneuraminate lyase; IPR005264) 452 
were identified using the UniProt database, this family identifier was used to extract protein 453 
sequences using Enzyme Function Initiative (EFI) Enzyme Similarity tool67. For the other 454 
proteins, the families found in the InterPro database were too large to be analysed, so the 455 
sequence BLAST tool was used with a maximum of 2500 protein sequences extracted. From 456 
this sequence similarity networks were generated and viewed in Cytoscape version 3.668. 457 
Cluster analysis Homologous gene clusters were identified for the R. gnavus ATCC 29149 458 
nan cluster45 using MultiGeneBlast69. The BCT (Bacteria) GenBank subdivision was queried 459 
with the sequence spanning locus tags RUMGMA_RS11835 – RUMGNA_RS11885 (from 460 
scaffold AAYG02000020_1). The data was manually curated, excluding all clusters that do 461 
not contain a predicted sialidase or are homologous to the functionally characterized S. 462 
pneumoniae NanC cluster47,70 and the clusters are summarized by organism and predicted 463 
gene content in Supplementary Table S5. 464 
 465 
RUMGNA_02695 enzymatic activity assay 466 
To assay RUMGNA_02695 activity against 2,7-anhydro-Neu5Ac, the purified recombinant 467 
protein was incubated in 100 μl reactions at 37 °C overnight with 1 mM 2,7-anhydro-468 
Neu5Ac, 50 mM sodium phosphate buffer pH 7.0 and 500 μM NADH, NAD, FAD or no 469 
cofactor. The reactions were dried using a Concentrator Plus (Eppendorf) for 1 h. Samples 470 
were then resuspended in 50 µl of water and 50 µl of reaction buffer (1.74 mg of 1,2-471 
Diamino-4,5-methylenedioxybenzene dihydrochloride (DMB, Carbosynth, UK), 324.6 µl 472 
MilliQ water, 88.6 µl glacial acetic acid, 58.2 µl of β-Mercaptoethanol and 79.3 µl of sodium 473 
hydrosulphite) and incubated for 2 h at 55 °C in the dark. The samples were then centrifuged 474 
for 1 min and filtered using a 0.45 µm filter into a glass HPLC vial and directly analysed by 475 
HPLC.  476 
DMB-labelled samples were analysed by injecting 10 μl onto a Luna 5 µm C-18(2) LC 477 
column 250x4.6 mm (Phenomenex) at 1 ml/min. Mobile phases methanol/acetonitrile/water 478 
were used for separation of fluorescently labelled sialic acids46. The settings of the 479 
fluorescence detector were 373 nm excitation and 448 nm emission. Samples were run 480 
alongside a Neu5Ac standard.  481 
To determine the kinetic parameters of RUMGNA_02695 enzymatic reaction, a coupled 482 
reaction with lactate dehydrogenase and sialic acid aldolase was carried out as described 483 
above but with 15 μg of RgNanA and 10 μg RUMGNA_02695 in each reaction. For the 484 
kinetics assays, 1, 0.4, 0.2, 0.1, 0.04, 0.02 and 0.01 mM 2,7-anhydro-Neu5Ac was used and 485 
the initial rate of reaction determined for each concentration in triplicate before analysis was 486 
performed by fitting the data to a Michaelis-Menten using Graph Pad Prism (V 5.03). 487 
Electrospray ionisation spray mass spectrometry (ESI-MS) analysis was performed using the 488 
Applied Biosystems 4000 Q-TRAP. The full 100 µl reaction was diluted with 500 ul of 50% 489 
Acetonitrile and 0.1 % formic acid and samples analysed in negative ion mode using direct 490 
injection. 491 
 492 
ClosTron mutagenesis 493 
R. gnavus mutants were generated using the ClosTron methodology56, which inserts an 494 
erythromycin resistance cassette into the gene of interest. The target site (270a) was 495 
identified using the Perutka method71. The re-targeted introns were synthesised and ligated 496 
into the pMTL007C-E2 vector by ATUM (MenloPark, USA). The plasmids were then 497 
transformed into E. coli CA434 using the heat-shock 42°C for 45 seconds followed by 2 min 498 
on ice before the recombinant clones were selected for chloramphenicol resistance (25 499 
µg/ml). Recombinant E. coli cells were grown overnight aerobically in 10 ml LB, 1 ml of the 500 
overnight culture was pelleted and washed with PBS. Continuing under anaerobic conditions 501 
the E. coli cell pellet was resuspended in 200 μl of an R. gnavus overnight culture and the 502 
cell suspension spotted onto a non-selective BHI-YH plate. Following incubation for 8 h at 37 503 
°C the bacteria were washed from the plate using PBS and plated onto BHI-YH 504 
supplemented with cycloserine (250 μg/ml) and thiamphenicol (15 μg/ml) and grown for 72 h 505 
to select against E. coli and for transfer of the plasmid to R. gnavus. Individual colonies were 506 
grown in non-selective BHI-YH broth overnight to allow expression of the plasmid and 507 
genomic recombination. The culture was then plated onto a BHI-YH medium containing 508 
cycloserine (250 μg/ml) and erythromycin (10 μg/ml) to select clones with successful 509 
genomic recombination. PCR and sequencing were used to confirm recombination in the 510 
gene of interest. 511 
Expression of the nan cluster genes in the generated mutants was assessed as described 512 
above using RNA samples from growth on YCFA supplemented with glucose. 513 
The ability of the mutants to utilise sialic acids and sialoconjugates was assessed by 514 
supplementing YCFA with 11.1 mM of 2,7-anhydro-Neu5Ac, 3’SL, glucose or Neu5Ac in 515 
triplicate 200 µl cultures in 96-well microtiter plates. The OD595 nm was measured hourly for 516 
10 h in an infinite F50 plate reader (Tecan, UK) housed within an anaerobic cabinet 517 
connected to Magellan V7.0 software. 518 
 519 
Saturation Transfer Difference (STD) NMR Spectroscopy.  520 
An amicon centrifuge filter unit with a 10 kDa MW cut-off was used to exchange the protein 521 
in 25 mM d19-2,2-bis(hydroxymethyl)-2,2′,2″-nitrilotriethanol pH* 7.4 (uncorrected for the 522 
deuterium isotope effect on the pH glass electrode) D2O buffer and 50 mM NaCl. 2,7-523 
anhydro-Neu5Ac and Neu5Ac were dissolved in 25 mM d19-2,2-bis(hydroxymethyl)-2,2′,2″-524 
nitrilotriethanol pH 7.4, 50 mM NaCl. Characterization of ligand binding by Saturation 525 
Transfer Difference NMR Spectroscopy72 was performed on a Bruker Avance 800.23 MHz at 526 
298 K. The on- and off-resonance spectra were acquired using a train of 50 ms Gaussian 527 
selective saturation pulses using a variable saturation time from 0.5 s to 4 s, for binding 528 
epitope mapping determination while only 0.5 s of saturation time for each selected 529 
frequency was used to perform the DEEP-STD NMR experiments42. The water signal was 530 
suppressed by using the excitation sculpting technique73, while the remaining protein 531 
resonances were filtered using a T2 filter of 40 ms. All the spectra were performed with a 532 
spectral width of 10 KHz and 32768 data points using 256 or 512 scans. This time due to the 533 
absence of a 3D structure it was impossible to derive the resonances for saturation of 534 
aliphatic and aromatic residues found in the binding site as required by the DEEP-STD NMR 535 
technique. Moreover, RgSBP being a high molecular weight protein the NMR spectra 536 
assignment is precluded. For this we adopted a search for druggable sites strategy using 4-537 
hydroxy-1-oxyl-2,2,6,6-tetramethylpiperidine (TEMPOL) as previously described74.  538 
1H-1H TOCSY spectra of the protein (500 μM) were acquired in the presence and in the 539 
absence of TEMPOL (2.5 mM and 12.5 mM). The spectra were performed with a spectral 540 
width of 10 kHz using a time domain of 2056 data points in the direct dimension and 32 541 
scans. The indirect dimension was acquired using the non-uniform sampling (NUS) 542 
technique acquiring a NUS amount of 50% of the original 256 increments resulting in 64 543 
hypercomplex points. The spectra were processed with the Topspin 3.1 compressed sensing 544 
(cs) routine. The final selected resonances were those identified by the TEMPOL PRE effect, 545 
and not overlapping with ligand signals. The DEEP-STD NMR data obtained were used to 546 
derive the average orientation of the ligand bound to RgSBP by averaging the DEEP-STD 547 
factors obtained from each saturated region. The DEEP-STD NMR and binding epitope 548 
mapping analysis were performed using previously published procedures42,74,75. 549 
 550 
Crystal structure determination 551 
Sitting drop vapour diffusion crystallisation experiments of RgNanA wt were set up at a 552 
concentration of 20 mg/ml and monitored using the VMXi beamline at Diamond Light 553 
Source76. The described RgNanA wild-type crystal structure was acquired from a crystal 554 
grown in the Morpheus screen (Molecular Dimensions), 0.2 M 1,6-hexandiol, 0.2 M 1-555 
butanol, 0.2 M 1,2-propanediol, 0.2 M 2-propanol, 0.2 M 1,4-butanediol, 0.2 M 1,3-556 
propanediol, 0.1 M Hepes/MOPS pH 6.5, 20% ethylene glycol, 10% PEG 8000. The 557 
diffraction experiment was performed on beamline I24 beamline at Diamond Light Source 558 
Ltd at 100K using a wavelength of 0.9686 Å. The data were processed with Xia2 making use 559 
of aimless, dials, and pointless (for data collection and refinement statistics see 560 
Supplementary Table S3). The structure was phased using MrBump through CCP4 online 561 
and Molrep77-79, by CdNaI from C. difficile (PDB 4woq) prepared using Chainsaw. 562 
Refinement was carried out using Refmac, Buster, and PDB redo80-84. Coot and ArpWarp 563 
were used for model building and Molprobity for structure validation85. It was not possible to 564 
crystallise RgNanA wt in the presence of Neu5Ac as it caused protein precipitation and 565 
RgNanA crystals dissolved in Neu5Ac soaking experiments, as also observed previously 566 
with P. multocida Neu5Ac aldolase53, possibly due to conformational changes during 567 
substrate binding or catalysis. Experiments with RgNanA K167A mutant were set up at 25 568 
mg/ml. Diffracting crystals grew in 0.1 M Tris/BICINE pH 8.5, 20% ethylene glycol, 100 mM 569 
MgCl2, 10% PEG 8000 and diffraction experiments performed on beamline I04 at Diamond 570 
Light Source using a wavelength of 0.9795 Å. The crystal structure was phased with 571 
PHASER using the RgNanA wild-type crystal structure86. A 60 second 5 mM Neu5Ac soak 572 
prior to freezing generated the RgNanA K167A Neu5Ac complex. Due to data anisotropy, we 573 
processed the data in autoPROC86,87 with the STARANISO option88 and used these data for 574 
refinement with Buster using the previously obtained models of RgNanA wild-type and 575 
K167A Neu5Ac complex. 576 
 577 
In vivo colonisation and analyses 578 
The impact of the nan deletion mutation on R. gnavus fitness was assessed by its ability to 579 
colonise germ-free C57BL/6J mice. Groups containing four 7-9 week old germ-free mice 580 
(two male, two female) were gavaged with 1x108 CFU of R. gnavus ATCC 29149 wild-type 581 
or antisense nan mutant in 100 µl PBS, individually or in combination. Sample size was 582 
selected following the 3 R's principles of reduction, replacement, refinement, whilst ensuring 583 
data collected allowed for statistical analysis, randomization was not possible due to the 584 
constraints of germ-free isolators, scientists were blinded for the FISH analysis. Care and 585 
treatment of animals was in accordance guidelines from and approval by the University of 586 
East Anglia Disease Modelling Unit and all animal experiments were conducted in strict 587 
accordance with the Home Office Animals (Scientific Procedures) Act 1986. Faecal samples 588 
were collected from each mouse at 3,7 and 14 days post gavage, and caecal content taken 589 
at day 14. DNA was extracted from these samples using the MP Biomedicals Fast 590 
DNA™ SPIN kit for Soil DNA extraction with the following modifications. The samples were 591 
resuspended in 978 µl of sodium phosphate buffer before being incubated at 4 °C for one 592 
hour following addition of 122 µl MT Buffer. The samples were then transferred to the lysing 593 
tubes and homogenised in a FastPrep® Instrument (MP Biomedicals) 3 times for 40 s at a 594 
speed setting of 6.0 with 5 min on ice between each bead-beating step. The protocol was 595 
then followed as recommended by the supplier.  596 
Colonisation was quantified using qPCR carried out in an Applied Biosystems 7500 Real-597 
Time PCR system (Life Technologies Ltd). In competition experiments, primers based on the 598 
insertion in the RgNanH gene were used to distinguish between wild-type and nan mutant. 599 
One pair of primers was designed to specifically target R. gnavus wild-type strain by 600 
spanning the area of insertion into the nan cluster and one pair of primers was designed to 601 
specifically amplify the inserted DNA, therefore targeting the nan mutant (Supplementary 602 
Table S6). The primers were between 18 and 23 nt-long, with a Tm of 59–60°C. Standard 603 
curves were prepared in triplicate for both primer pairs using a 10-fold serial dilution of DNA 604 
corresponding to 1x107 copies of RgNanH/2ul to 1x102 copies/2ul diluted in 5 µg/ml Herring 605 
sperm DNA. The standard curves showed a linear relationship of log input DNA vs. the 606 
threshold cycle (CT), with acceptable values for the slopes and the regression coefficients 607 
(R2). The dissociation curves were also performed to check the specificity of the amplicons. 608 
Each qPCR reaction (10 µl) was then carried out in triplicate with 2 µl of 1 ng/μl DNA (diluted 609 
in 5 µg/ml Herring sperm DNA) and 0.2 µM of each primer, using the QuantiFast SYBR 610 
Green PCR kit (Qiagen) according to the manufacturer’s instructions (except that the 611 
combined annealing/extension step was extended to 35 s instead of 30 s). Data obtained 612 
were analysed using the prepared standard curves. 613 
 614 
RNAseq analysis 615 
For RNAseq analysis, the colonic tissues from mono-colonised mice were gently washed 616 
and stored in RNAlater at -80ºC until extraction. RNA extraction was performed using the 617 
RNeasy mini kit (QIAGEN) following the manufacturer’s instructions for purification of total 618 
RNA from animal tissues, including the on-column DNase digestion. Homogenisation was 619 
achieved with acid washed glass beads using the FastPrep®-24 (MP Biomedicals, Solon, 620 
USA) by 3 intermittent runs of 30 s at 6 m/s speed every 5 min, at room temperature. Elution 621 
was performed as recommended with 50 μl RNAse-free water. The quality and 622 
concentration of the RNA samples was assessed using NanoDrop 2000 Spectrophotometer 623 
Nanodrop, the Qubit RNA HS assay on Qubit® 2.0 fluorometer (Life Technologies) and 624 
Agilent RNA 600 Nano kit on Agilent 2100 Bioanalyzer (Agilent Technologies, Stockport, 625 
UK). 626 
RNAseq was carried out by Novogene (HK) (Hong Kong). Briefly, mRNA was enriched using 627 
oligo(dT) beads, fragmented randomly in fragmentation buffer, followed by cDNA synthesis 628 
using random hexamers and reverse transcriptase. After first-strand synthesis, a custom 629 
second-strand synthesis buffer (Illumina) was added with dNTPs, RNase H and Escherichia 630 
coli polymerase I to generate the second strand by nick-translation. The final cDNA library 631 
was obtained after a round of purification, terminal repair, A-tailing, ligation of sequencing 632 
adapters, size selection and PCR enrichment. Library concentration was first quantified 633 
using a Qubit® 2.0 fluorometer (Life Technologies), and then diluted to 1 ng/µl before 634 
checking insert size on an Agilent 2100 and quantifying to greater accuracy by qPCR (library 635 
activity >2 nM). Sequencing of the library was carried out on Illumina Hiseq platform and 636 
125/150 bp paired-end reads were generated. 637 
FASTQ files containing base calls and quality information for all reads that passed quality 638 
filtering were generated. Reads were mapped to the mouse reference genome using 639 
TopHat289. The mismatch parameter was set to two, and other parameters were set to 640 
default. Appropriate parameters were also set, such as the longest intron length. Filtered 641 
reads were used to analyze the mapping status of RNA-seq data to the reference genome. 642 
The HTSeq software was used to analyze the gene expression levels, using the union 643 
mode90. In order for the gene expression levels estimated from different genes and 644 
experiments to be comparable, the FPKM (Fragments Per Kilobase of transcript sequence 645 
per Millions base pairs sequenced) was used to take into account the effects of both 646 
sequencing depth and gene length. The differential gene expression analysis was carried 647 
out using the DESeq package90 and the readcounts from gene expression level analysis as 648 
input data. An adjusted p value (padj) cut-off of 0.05 was used to determine differential 649 
expressed transcripts. 650 
 651 
Fluorescent in situ hybridization (FISH) staining  652 
For FISH analysis, the colonic tissue was fixed in methacarn (60% dry methanol, 30% 653 
chloroform and 10% acetic acid), processed and embedded in paraffin as previously 654 
described2. Tissue sections were prepared at 8-10 µm. Paraffin sections were dewaxed and 655 
washed in 95% ethanol. The tissue sections were incubated with 100 µl of Alexa Fluor 555-656 
conjugated Erec482 probe (5’ – GCTTCTTAGTCARGTACCG -3’) at a concentration of 10 657 
ng/µl, in hybridisation buffer (20 mM Tris-HCl, pH 7.4, 0.9M NaCl, 0.1% SDS) at 50oC 658 
overnight. The sections were then incubated in a 50oC prewarmed wash buffer (20m M Tris-659 
HCl, pH 7.4, 0.9 M NaCl) for 20 min. All subsequent steps were performed at 4oC. The 660 
sections were washed with PBS, the blocked with TNB buffer (0.5% w/v blocking reagent in 661 
100 mM Tris-HCl, pH 7.5, 150 mM NaCl) supplemented with 5% goat serum. To detect 662 
mucin, the sections were then counterstained with a Muc2 antibody (sc-15334) at 1:100 663 
dilution in TNB buffer overnight. The sections were washed in PBS, then goat anti-rabbit 664 
antibodies (diluted 1:500) were used for immunodetection. The sections were counterstained 665 
with Sytox blue (S11348, ThermoFisher) diluted 1:1000 in PBS and mounted in Prolong gold 666 
anti-fade mounting medium. The slides were imaged using a Leica TCS SP2 confocal 667 
microscope with a x63 objective. The distance between the leading front of bacteria and the 668 
base of the mucus layer was measured with FIJI91. A total of 70 images from 8 mice were 669 
analysed, and scientists were blinded for the analysis due the subjectivity of determining the 670 
leading front of bacteria and base of the mucus layer.  The association between genotype 671 
and distances was estimated by a linear mixed model, including fixed effects of genotype 672 
and area and random effects of mouse and each individual image. There was substantial 673 
spatial correlation between adjacent observations and so an AR(1) correlation structure was 674 
added. The resulting model had no residual autocorrelation as judged by visual inspection of 675 
autocorrelation function.  The nmle package version 3.1-137 using R version 3.5.3 was used 676 
to estimate the model. 677 
 678 
Data Availability 679 
Genome and protein sequences are available from NCBI and referenced within the text or 680 
supplementary information. Accession numbers of all genomes used for multigene 681 
alignments, are available in Supplementary Table 5. Raw FASTQ files for the RNA-seq 682 
libraries were deposited to the NCBI Sequence Read Archive (SRA), and have been 683 
assigned BioProject accession PRJNA559470. The crystal structures described in this 684 
paper have been deposited in the protein data bank (ODB) with the following identifiers 685 
6RAB (WT), 6RB7 (K167A), and 6RD1 (K167A Neu5Ac complex). All other data are 686 
available upon request from the corresponding author. 687 
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 Figure legends 1006 
Figure 1 R. gnavus ATCC 29149 nan operon a) Diagram depicting the genomic 1007 
organisation of the nan operon RUMGNA_02701 (putative sialic acid esterase; tan) 1008 
RUMGNA_02700 (putative YhcH family protein; dark blue), RUMGNA_02699 (predicted 1009 
transcriptional regulator; purple), RUMGNA_02698 – 02696 (putative sialic acid ABC 1010 
transporter of the SAT2 family; green), RUMGNA_02695 (putative oxidoreductase, pink), 1011 
RUMGNA_02694 (RgNanH (Intramolecular trans sialidase), gold), RUMGNA_02693 (NanE 1012 
(epimerase), blue), RUMGNA_02692 (NanA (aldolase), dark green), RUMGNA_02691 1013 
(kinase) (NanK, red). b) qPCR analysis showing fold changes in expression of nan genes 1014 
when R. gnavus was grown with 3’SL or 2,7-anhydro-Neu5Ac compared to glucose using 1015 
∆∆Ct calculation. Error represent standard deviation and are based on three biological 1016 
replicates analysed in triplicate. Statistical significance was determined using a 1-way 1017 
ANOVA with a Dunnett’s multiple comparison test. NS – no significant change in expression 1018 
(p > 0.05), * - p 0.05 – 0.01, ** - p 0.01 – 0.001, *** - p < 0.001.  1019 
 1020 
Figure 2 Steady-state fluorescence analysis of ligand binding to RgSBP.  Fluorescence 1021 
emission spectrum of 0.5 µM RgSBP excited at 297 nm in the presence or absence of a) 1022 
2,7-anhydro-Neu5Ac or b) Neu5Ac. The data shown are representative of triplicate readings. 1023 
c) Titration of 0.5 µM RgSBP with 2,7-anhydro-Neu5Ac. The data represents the mean of 1024 
triplicate readings. d) Displacement of Neu5Ac with 2,7-anhydro-Neu5Ac, six sequential 1025 
additions of 10 μM Neu5Ac to 0.5 µM RgSBP followed by one addition of 10 µM 2,7-1026 
anhydro-Neu5Ac, and displacement of 2,7-anhydro-Neu5Ac with Neu5Ac, one addition of 10 1027 
μM 2,7-anhydro-Neu5Ac followed by 6 subsequent additions of 10 μM Neu5Ac. The data 1028 
shown are representative of triplicate experiments, the signal peaks are artefacts attributed 1029 
to external light during sample addition.  1030 
Figure 3 Biophysical analysis of ligand binding to RgSBP. ITC Isotherms of RgSBP 1031 
binding to a) 2,7-anhydro-Neu5Ac or b) Neu5Ac, showing both DP – differential power and 1032 
∆H – enthalpy change. The data shown are representative of triplicate experiments. c) 1033 
Saturation Transfer Difference (STD) NMR binding epitope mapping of 2,7-anhydro-Neu5Ac 1034 
interacting with RgSBP. The initial slopes STD0 (%) were normalized against the highest 1035 
STD0, assigned as 100%. The obtained factors were then classified as weak (0-60 %), 1036 
intermediate (60-80 %), and strong (80-100%) and used to identify the close contacts found 1037 
at the interface of binding, data is representative of triplicate readings d) Average Differential 1038 
Epitope Mapping (DEEP) STD factors for 2,7-anhydro-Neu5Ac obtained saturating RgSBP 1039 
in spectral regions 0.6, 0.78, 1.44 ppm for aliphatic and 7.5, 7.23, 7.27 ppm for aromatic 1040 
residues. Each differential mapping epitope obtained using different saturation frequencies 1041 
are combined and the average DEEP STD is calculated resulting in five points for each 1042 
frequency and a total of fifteen points for each proton receiving saturation. The data reported 1043 
are the mean ± SEM of a sample of data of fifteen points for each proton receiving 1044 
saturation. 1045 
Figure 4 R. gnavus sialic acid aldolase enzymatic reaction. a) Change of A340nm over 1046 
time using R. gnavus sialic acid aldolase (RgNanA) with Neu5Ac (pink) or 2,7-anhydro-1047 
Neu5Ac (orange), or E. coli sialic acid aldolase (EcNanA) with Neu5Ac (black) or 2,7-1048 
anhydro-Neu5Ac (green) reactions coupled to lactate dehydrogenase, error bars represent 1049 
standard error from 3 independent experiments. b) Michaelis-Menten plot of RgNanA rate of 1050 
reaction with increasing concentration of Neu5Ac, error bars represent standard error. The 1051 
rate of reaction at each concentration (µM NADH) was determined in triplicate by measuring 1052 
A340nm change using a standard curve. The mean value is plotted with standard error of the 1053 
meaning shown with error bars c) Cartoon representation of the wild type RgNanA crystal 1054 
structure showing the (β/α8) TIM barrel organisation and Lys167 as yellow sticks. d) The 1055 
RgNanA K167A active site is shown in orange with bound Neu5Ac in the open-chain ketone 1056 
form shown in cyan. The green mesh represents the Neu5Ac Fo-Fc difference map at the 3σ 1057 
level (for a stereo image of Neu5Ac and Fo-Fc difference map see Supplementary Figure 1058 
5d). Hydrogen bonding interactions are depicted using black dashed lines. In addition, the 1059 
unbound RgNanA wt active site is shown in grey. 1060 
Figure 5 RUMGNA_02695 catalyses the conversion of 2,7-anhydro-Neu5Ac to Neu5Ac. 1061 
a) High Performance Liquid Chromatography (HPLC) expand acronyms number replicates 1062 
with same outcome analysis of DMB labelled RUMGNA_02695 reactions with 2,7-anhydro-1063 
Neu5Ac using different co-factors. NAD (black), NADH (pink), FAD (blue), no co-factor 1064 
(brown), and a Neu5Ac standard (green), data is representative of five independent 1065 
experiments. b) Michaelis-Menten plot of the rate of reaction for RUMGNA_02695 with 1066 
increasing concentration of 2,7-anhydro-Neu5Ac. The rate of reaction (µM NADH) at each 1067 
concentration was determined in triplicate by measuring A340nm change and using a 1068 
standard curve, the mean value is plotted with standard error of the meaning shown with 1069 
error bars 1070 
Figure 6 Colonisation of germ-free C57BL/6J mice with R. gnavus ATCC 29149 wild-1071 
type or nan mutant strains. Mice were monocolonised with a and b sample size (n) and 1072 
define centre measure mean(a) R. gnavus wild-type (black; n = 4) or nan mutant (red; n = 4) 1073 
strains individually or (b) in competition (n = 4). Mice were orally gavaged with 1x10
8
 of each 1074 
strain, faecal samples were analysed at 3,7 and 14 days after inoculation and caecal 1075 
samples at 14 days after inoculation using qPCR, centre line denotes the mean. (c) 1076 
Fluorescent in situ hybridisation (FISH) and immunostaining of the colon from R. gnavus 1077 
monocolonised C57BL/6 mice. R. gnavus ATCC 29149 and R. gnavus nan mutant are 1078 
shown in red. The mucus layer is shown in green and an outline of the mucus is shown in 1079 
the first panels. Cell nuclei were counterstained with Sytox blue, shown in blue. Scale bar: 1080 
20 μm. Image is representative of 70 total images (d) Quantification of the distance between 1081 
the leading front of bacteria and the base of the mucus layer. A total of 70 images of stained 1082 
colon from 8 R. gnavus monocolonised mice were analysed. The asterisks (***) show the 1083 
significance (P=0.0135, by linear mixed model analysis, including fixed effects of genotype 1084 
and area and random effects of mouse and each individual image.  There was substantial 1085 
spatial correlation between adjacent observations and so an AR(1) correlation structure was 1086 
added.  The resulting model had no residual autocorrelation as judged by visual inspection 1087 
of autocorrelation function.  The nmle package version 3.1-137 using  R version 3.5.3 was 1088 
used to estimate the model), centre point indicates the mean, box limits, upper and lower 1089 
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